Pfizer Inc. said it has received requests for information and documents from the U.S. Justice Department related to payments to physicians for prescription medicines, according to a regulatory filing on Wednesday. The world’s largest drug maker also withdrew an application to market Caduet, a combination hypertension and cholesterol pill, in 12 European regions, according to the U.S. Securities and Exchange Commission filing.
